[Myasthenia gravis].
D001327:Autoimmune Diseases; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D006801:Humans; D009157:Myasthenia Gravis / Q000209:etiology / Q000276:immunology / Q000628:therapy; D009388:Neostigmine / Q000627:therapeutic use; D010830:Physostigmine / Q000627:therapeutic use; D011729:Pyridostigmine Bromide / Q000627:therapeutic use; D013934:Thymectomy; D013945:Thymoma / Q000150:complications; D013953:Thymus Neoplasms / Q000150:complications
D002800:Cholinesterase Inhibitors; D009388:Neostigmine; D010830:Physostigmine; D011729:Pyridostigmine Bromide
Myasthenia gravis